ReviewCancers2020
Recent Advances in Desmoid Tumor Therapy.
Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 47 citations in OpenAlex.
- Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026Trial
- Review
- UPLC-LCMS-Based Method Development, Validation, Forced Degradation, and Impurity Profiling of Nirogacestat Drug Substance.Current topics in medicinal chemistry · 2026Article
- Case Report: Ureteral obstruction reveals rare underlying fibro-inflammatory, infiltrative, and proliferative disorders: report of four cases.Frontiers in immunology · 2026Article
- Single-Cell Transcription Reveals the Fibroblast Heterogeneity and Neural Cells' Significance in Desmoid Fibromatosis.Cancer science · 2025Article
- Long-term outcome and prognostic factors after chest wall resection and reconstruction.Interdisciplinary cardiovascular and thoracic surgery · 2025Article
- A giant sporadic intra-abdominal desmoid tumor resection: a rare case report.International journal of surgery case reports · 2025Article
- Pregnancy-Associated Giant Abdominal Desmoid Tumor: A Case Report of Active Surveillance and Surgical Management.International journal of women's health · 2025Article
- Evolution of Initial Treatment for Desmoid Tumors.Annals of surgical oncology · 2024Article
- New strategies in soft tissue sarcoma treatment.Journal of hematology & oncology · 2024Review
- Aggressive fibromatosis of the sigmoid colon: A case report.World journal of gastrointestinal oncology · 2024Article
- Article
- Desmoid Fibromatosis of the Anterior Abdominal Wall in Pregnancy: A Case Report and Review of the Literature.Diseases (Basel, Switzerland) · 2024Article
- Initial treatment for surgery-naïve desmoid tumors by high intensity focused ultrasound.Frontiers in oncology · 2024Article
- Giant abdominal desmoid-type fibromatosis.Autopsy & case reports · 2024Article
- A clinician's perspective on the new organ mesentery and non-vascular mesenteropathies.Frontiers in physiology · 2024Review
- Role of Surgery in the Treatment of Abdominal Desmoid Fibromatosis: A Single-Center Experience.Indian journal of surgical oncology · 2023Article
- Desmoid Tumors: A Comprehensive Review.Advances in therapy · 2023Review
- Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey.Frontiers in oncology · 2023Article
- Clinical Prognostic Factors and Integrated Multi-Omics Studies Identify Potential Novel Therapeutic Targets for Pediatric Desmoid Tumor.Biological procedures online · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The desmoid tumor is a locally aggressive proliferative disease within the family of soft-tissue sarcomas. Despite its relatively good prognosis, the clinical management of desmoid tumors requires constant multidisciplinary evaluation due to its highly variable clinical behavior. Recently, active surveillance has being regarded as the appropriate strategy at diagnosis, as indolent persistence or spontaneous regressions are not uncommon. Here, we review the most recent advances in desmoid tumor therapy, including low-dose chemotherapy and treatment with tyrosine kinase inhibitors. We also explore the recent improvements in our knowledge of the molecular biology of this disease, which are leading to clinical trials with targeted agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.